Skip to main content

Table 2 Patient characteristics

From: GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment

Pathological responseAll patients (pCR + Non-pCR)pCRNon-pCR
Age (years)
 Median (range)61.7 (33–69)65.3 (38–69)58.1 (34–68)
Subtype
 TN633
 Her2+1192
 ESR+/Her2-321
Tumor size stage
 T0110
 T113103
 T2101
 T3532
Nodal stage
 N0532
 N11091
 N2220
 N3321
Total20146
  1. ESR Estrogen Receptor, pCR pathological Complete Response, TN triple negative